Technology platform

Rapid AAV production

• 7 days viral production cycle
• Meet customized titer requirements.

cceAAV production

• Low fraction of unexpected partial genomes.
• Reducing safety concerns 

Parallel AAV production

• High through-put capsids screening 
• High through-put GOI screening 

Contact Us